BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 11981827)

  • 1. Resistance to TGF-beta1-mediated growth inhibition correlates with sustained Smad2 phosphorylation in primary murine splenocytes.
    Feldmann K; Sebald W; Knaus P
    Eur J Immunol; 2002 May; 32(5):1393-402. PubMed ID: 11981827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.
    Nakao A; Imamura T; Souchelnytskyi S; Kawabata M; Ishisaki A; Oeda E; Tamaki K; Hanai J; Heldin CH; Miyazono K; ten Dijke P
    EMBO J; 1997 Sep; 16(17):5353-62. PubMed ID: 9311995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antifibrotic effects of relaxin in human renal fibroblasts are mediated in part by inhibition of the Smad2 pathway.
    Heeg MH; Koziolek MJ; Vasko R; Schaefer L; Sharma K; Müller GA; Strutz F
    Kidney Int; 2005 Jul; 68(1):96-109. PubMed ID: 15954899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
    Poncelet AC; de Caestecker MP; Schnaper HW
    Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The transcriptional co-activator P/CAF potentiates TGF-beta/Smad signaling.
    Itoh S; Ericsson J; Nishikawa J; Heldin CH; ten Dijke P
    Nucleic Acids Res; 2000 Nov; 28(21):4291-8. PubMed ID: 11058129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor-beta- and Activin-Smad signaling pathways are activated at distinct maturation stages of the thymopoeisis.
    Rosendahl A; Speletas M; Leandersson K; Ivars F; Sideras P
    Int Immunol; 2003 Dec; 15(12):1401-14. PubMed ID: 14645149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unique and redundant roles of Smad3 in TGF-beta-mediated regulation of long bone development in organ culture.
    Alvarez J; Serra R
    Dev Dyn; 2004 Aug; 230(4):685-99. PubMed ID: 15254903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signaling through the Smad pathway by insulin-like growth factor-binding protein-3 in breast cancer cells. Relationship to transforming growth factor-beta 1 signaling.
    Fanayan S; Firth SM; Baxter RC
    J Biol Chem; 2002 Mar; 277(9):7255-61. PubMed ID: 11751851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
    Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
    Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of internalization in transforming growth factor beta1-induced Smad2 association with Smad anchor for receptor activation (SARA) and Smad2-dependent signaling in human mesangial cells.
    Runyan CE; Schnaper HW; Poncelet AC
    J Biol Chem; 2005 Mar; 280(9):8300-8. PubMed ID: 15613484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smad3 is essential for TGF-beta 1 to suppress IL-2 production and TCR-induced proliferation, but not IL-2-induced proliferation.
    McKarns SC; Schwartz RH; Kaminski NE
    J Immunol; 2004 Apr; 172(7):4275-84. PubMed ID: 15034041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional characterization of transforming growth factor beta signaling in Smad2- and Smad3-deficient fibroblasts.
    Piek E; Ju WJ; Heyer J; Escalante-Alcalde D; Stewart CL; Weinstein M; Deng C; Kucherlapati R; Bottinger EP; Roberts AB
    J Biol Chem; 2001 Jun; 276(23):19945-53. PubMed ID: 11262418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of responsiveness to TGF-beta1 in a thyroid carcinoma cell line with functional type I and type II TGF-beta receptors and Smad proteins, suggests a novel mechanism for TGF-beta insensitivity in carcinoma cells.
    Heldin NE; Bergström D; Hermansson A; Bergenstråhle A; Nakao A; Westermark B; ten Dijke P
    Mol Cell Endocrinol; 1999 Jul; 153(1-2):79-90. PubMed ID: 10459856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
    Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
    Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth inhibition by insulin-like growth factor-binding protein-3 in T47D breast cancer cells requires transforming growth factor-beta (TGF-beta ) and the type II TGF-beta receptor.
    Fanayan S; Firth SM; Butt AJ; Baxter RC
    J Biol Chem; 2000 Dec; 275(50):39146-51. PubMed ID: 10993898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-talk between ERK MAP kinase and Smad signaling pathways enhances TGF-beta-dependent responses in human mesangial cells.
    Hayashida T; Decaestecker M; Schnaper HW
    FASEB J; 2003 Aug; 17(11):1576-8. PubMed ID: 12824291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic analysis of the TGF-beta/Smad signalling pathway in the rhabdomyosarcoma cell line RD.
    Wang H; Yang GH; Bu H; Zhou Q; Guo LX; Wang SL; Ye L
    Int J Exp Pathol; 2003 Jun; 84(3):153-63. PubMed ID: 12974945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Augmented cytoplasmic Smad4 induces acceleration of TGF-beta1 signaling in renal tubulointerstitial cells of hereditary nephrotic ICGN mice with chronic renal fibrosis; possible role for myofibroblastic differentiation.
    Goto Y; Manabe N; Uchio-Yamada K; Yamaguchi-Yamada M; Inoue N; Yamamoto Y; Ogura A; Nagano N; Miyamoto H
    Cell Tissue Res; 2004 Feb; 315(2):209-21. PubMed ID: 14615933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smad proteins exist as monomers in vivo and undergo homo- and hetero-oligomerization upon activation by serine/threonine kinase receptors.
    Kawabata M; Inoue H; Hanyu A; Imamura T; Miyazono K
    EMBO J; 1998 Jul; 17(14):4056-65. PubMed ID: 9670020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGF-beta induces proangiogenic and antiangiogenic factors via parallel but distinct Smad pathways.
    Nakagawa T; Li JH; Garcia G; Mu W; Piek E; Böttinger EP; Chen Y; Zhu HJ; Kang DH; Schreiner GF; Lan HY; Johnson RJ
    Kidney Int; 2004 Aug; 66(2):605-13. PubMed ID: 15253713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.